Agreed dkayed, I love to use peer valuation as part of my analysis too.
The thing is, MXC just got sold down into despite that ann.
The market is not liking these updates, which brings it back to Sidage's point.
Technically everything is going well, the patients are exponentially growing and so on.
So why does the market not favor these stocks?
Either fallen out of favor for now, or re-evaluation as to how much a patient is worth, so both MXC and AGH affected.
Rebound time, page-573
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.002(8.00%) |
Mkt cap ! $10.94M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.7¢ | 2.5¢ | $45.16K | 1.746M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1010657 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 786608 | 5 |
View Market Depth
| Last trade - 14.32pm 13/09/2024 (20 minute delay) ? |
| AGH (ASX) Chart |